PDCA循环管理法用于静脉用质子泵抑制剂用药管理效果分析OACSTPCD
Application Effect of PDCA Cycle Management Method in the Medication Management of Intravenous Proton Pump Inhibitors
目的 提高医院静脉用质子泵抑制剂(PPI)合理用药水平.方法 医院组建品管圈活动小组,运用PDCA循环管理法确定管控目标并开展静脉用PPI用药管理,比较干预前(2022 年 1 月至 2 月)及干预后(2022 年 5 月至 6 月)静脉用PPI住院医嘱开具情况及其合理性,分析不合理类别并进行针对性改进.结果 干预前,患者静脉用PPI不合理使用类别主要为无适应证用药、疗程不合理.干预后,患者静脉用PPI使用率由 24.93%降至 20.25%,合理使用率由 52.00%升至 92.00%,均基本达到既定目标(20%,85%).结论 医院开展PDCA循环管理,可提高静脉用PPI合理用药水平,提升医院药学服务质量.
Objective To promote the rational use of intravenous proton pump inhibitors(PPIs)in hospitals.Methods A quality control circle team was set up in the hospital,the PDCA cycle management method was used to define the control objectives and carry out the medication management of intravenous PPIs.The prescribing of inpatient orders for intravenous PPIs and its rationality before intervention(January to February 2022)and after intervention(May to June 2022)was compared,and irrational types were analyzed and targeted measures were taken.Results The main types of irrational use of intravenous PPIs in patients were medication without indication and inappropriate treatment duration before intervention.After intervention,the use rate of intravenous PPIs in patients decreased from 24.93%to 20.25%,and the rational use rate increased from 52.00%to 92.00%,generally reaching the intended targets(20%,85%).Conclusion The application of PDCA cycle management in hospitals can promote the rational use of intravenous PPIs and improve the quality of pharmaceutical care.
赵金卫;孔冕;吴晓丽
南京医科大学附属淮安第一医院,江苏 淮安 223300
药学
PDCA循环品管圈静脉用药质子泵抑制剂前置审方合理用药药事管理
PDCA cyclequality control circleintravenous medicationproton pump inhibitorpre-review prescriptionrational drug usepharmaceutical administration
《中国药业》 2024 (016)
18-21 / 4
江苏省药学会-天晴医院药学基金[Q202148].
评论